Andrew Noymer, UCI associate professor of public health said, “The trials are being run with more transparency than ever before, so I have great faith in getting a fair result from the vaccine process. … We’re also concerned with the efficacy because the FDA here in the United States has said they will approve vaccines with 50% or better efficacy and we have to anticipate that some people who are vaccinated will still get the disease, if indeed, the vaccine is only 50% effective.”
The race for a Covid-19 vaccine: Are lives at risk as countries try to find a quick fix?
France24, Oct. 14, 2020 (Video)
October 14, 2020